Published in Vaccine on August 13, 2010
Immunization delivered by lentiviral vectors for cancer and infectious diseases. Immunol Rev (2011) 1.18
Gene therapy on the move. EMBO Mol Med (2013) 1.10
Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol (2012) 0.98
Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART. Gene Ther (2013) 0.93
Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice. Mol Ther (2013) 0.87
Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci (2014) 0.85
Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice. PLoS One (2012) 0.85
Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies. Front Oncol (2014) 0.84
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells? Oncoimmunology (2013) 0.83
Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles. PLoS One (2013) 0.82
Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines. Retrovirology (2012) 0.81
A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria. PLoS One (2012) 0.81
Retroviral and lentiviral vectors for the induction of immunological tolerance. Scientifica (Cairo) (2012) 0.80
A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. Vaccine (2012) 0.79
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors. Mol Ther Methods Clin Dev (2015) 0.79
Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector. PLoS One (2014) 0.79
Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells. J Biol Eng (2011) 0.78
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines. J Immunol Res (2015) 0.77
Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals. Mol Ther Methods Clin Dev (2014) 0.77
Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene. J Cancer Res Clin Oncol (2013) 0.76
Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo. Mol Ther Nucleic Acids (2012) 0.76
Recent Advances in Lentiviral Vaccines for HIV-1 Infection. Front Immunol (2016) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science (2002) 17.71
A third-generation lentivirus vector with a conditional packaging system. J Virol (1998) 16.07
Taking dendritic cells into medicine. Nature (2007) 11.82
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol (2002) 9.45
A quantitative assay for HIV DNA integration in vivo. Nat Med (2001) 8.67
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol (2006) 5.58
T cell memory. Annu Rev Immunol (1998) 5.20
Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 4.28
Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol (1996) 2.82
Effective gene therapy with nonintegrating lentiviral vectors. Nat Med (2006) 2.70
Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther (2006) 2.34
Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol (2008) 2.05
Gene therapy: promises and problems. Annu Rev Genomics Hum Genet (2001) 1.82
Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther (2007) 1.81
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci U S A (2006) 1.74
Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol (2002) 1.66
A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med (1996) 1.63
Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J Virol (2004) 1.56
Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther (2004) 1.52
Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther (2009) 1.47
Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J Virol (1998) 1.44
Comparison of lentiviral vector titration methods. BMC Biotechnol (2006) 1.42
Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol (2008) 1.35
Successful immunization with a single injection of non-integrating lentiviral vector. Mol Ther (2007) 1.31
Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Gene Ther (2006) 1.30
DC-SIGN and immunoregulation. Cell Mol Immunol (2006) 1.29
Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum Gene Ther (2002) 1.27
Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J Virol (2009) 1.24
A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Mol Ther (2008) 1.23
Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One (2008) 1.16
Use of nonintegrating lentiviral vectors for gene therapy. Hum Gene Ther (2007) 1.04
Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine. Hum Gene Ther (2005) 1.04
HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc Natl Acad Sci U S A (2009) 0.98
From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy. J Gene Med (2006) 0.96
Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity. Hum Gene Ther (2009) 0.90
Lentiviral transduction of human dendritic cells. Methods Mol Biol (2004) 0.89
Lentiviral vectors for HIV disease prevention and treatment. Vaccine (2009) 0.83
Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens. Mol Ther (2000) 0.79
MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol (2009) 3.72
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res (2006) 3.28
Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol (2008) 2.05
FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res (2008) 2.01
Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res (2009) 1.96
MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem (2011) 1.88
High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886). Cancer Biol Ther (2009) 1.86
Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo. PLoS One (2010) 1.78
MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J Immunol (2010) 1.74
Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A (2006) 1.71
Quantification of nanoscale nuclear refractive index changes during the cell cycle. J Biomed Opt (2011) 1.25
Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J (2009) 1.25
A designed phenylalanyl-tRNA synthetase variant allows efficient in vivo incorporation of aryl ketone functionality into proteins. J Am Chem Soc (2002) 1.22
Immunization delivered by lentiviral vectors for cancer and infectious diseases. Immunol Rev (2011) 1.18
EUS-guided transhepatic cholangiography: report of 6 cases. Gastrointest Endosc (2005) 1.15
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood (2008) 1.14
REST regulates DYRK1A transcription in a negative feedback loop. J Biol Chem (2011) 1.14
Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Mol Immunol (2008) 1.06
Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology (2013) 1.04
Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells. Biochem Pharmacol (2012) 1.03
Site-specific labeling of enveloped viruses with quantum dots for single virus tracking. ACS Nano (2008) 1.02
Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity. Mol Pharm (2014) 0.98
HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc Natl Acad Sci U S A (2009) 0.98
Discovery and characterization of a group of fungal polycyclic polyketide prenyltransferases. J Am Chem Soc (2012) 0.98
Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials (2013) 0.98
Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Mol Ther (2011) 0.97
Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum Gene Ther (2008) 0.96
Protein nanocapsule weaved with enzymatically degradable polymeric network. Nano Lett (2009) 0.95
A functional polymorphism in the TIM-1 gene is associated with asthma in a Chinese Han population. Int Arch Allergy Immunol (2007) 0.94
PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines. Mol Ther (2012) 0.93
Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials (2011) 0.93
Nuclear nano-morphology markers of histologically normal cells detect the "field effect" of breast cancer. Breast Cancer Res Treat (2012) 0.93
Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis. Expert Opin Pharmacother (2013) 0.92
Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Cardiol (2010) 0.91
Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity. Hum Gene Ther (2009) 0.90
Genome mining of a prenylated and immunosuppressive polyketide from pathogenic fungi. Org Lett (2013) 0.90
Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates. ACS Nano (2011) 0.90
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model. J Immunol (2008) 0.90
Altered resting brain function and structure in professional badminton players. Brain Connect (2012) 0.90
IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells. Mol Cancer Ther (2013) 0.89
Batch fabrication of high-performance planar patch-clamp devices in quartz. Adv Mater (2010) 0.87
Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors. J Biol Eng (2009) 0.87
Design of a bacterial host for site-specific incorporation of p-bromophenylalanine into recombinant proteins. J Am Chem Soc (2006) 0.87
Pulsatile shear stress increased mitochondrial membrane potential: implication of Mn-SOD. Biochem Biophys Res Commun (2009) 0.86
Event-related potential effects of superior action anticipation in professional badminton players. Neurosci Lett (2011) 0.86
Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice. PLoS One (2012) 0.85
Synthetic niches for differentiation of human embryonic stem cells bypassing embryoid body formation. J Biomed Mater Res B Appl Biomater (2013) 0.85
Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting. Biotechnol Bioeng (2008) 0.84
Clickable protein nanocapsules for targeted delivery of recombinant p53 protein. J Am Chem Soc (2014) 0.84
Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule. Virol J (2010) 0.84
Endoprotease-mediated intracellular protein delivery using nanocapsules. ACS Nano (2011) 0.84
Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer. Genes Chromosomes Cancer (2012) 0.84
Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins. Microsc Res Tech (2010) 0.83
Regulator of calcineurin 1 gene transcription is regulated by nuclear factor-kappaB. Curr Alzheimer Res (2014) 0.83
Type I IFN inhibits innate IL-10 production in macrophages through histone deacetylase 11 by downregulating microRNA-145. J Immunol (2013) 0.83
A functional polymorphism in the SPINK5 gene is associated with asthma in a Chinese Han Population. BMC Med Genet (2009) 0.82
An autosomal dominant cataract locus mapped to 19q13-qter in a Chinese family. Mol Vis (2011) 0.82
Introduction of an aliphatic ketone into recombinant proteins in a bacterial strain that overexpresses an editing-impaired leucyl-tRNA synthetase. Chembiochem (2009) 0.82
Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery. Biomed Res Int (2013) 0.82
Estrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysis. Medicine (Baltimore) (2015) 0.82
Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy. Curr Pharm Des (2015) 0.81
Visualization of DC-SIGN-mediated entry pathway of engineered lentiviral vectors in target cells. PLoS One (2013) 0.81
Lentiviral vectors for immune cells targeting. Immunopharmacol Immunotoxicol (2010) 0.81
Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule. Biotechnol Bioeng (2009) 0.81
Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins. Virus Res (2011) 0.81
Expectation enhances event-related responses to affective stimuli. Neurosci Lett (2012) 0.81
In vitro differentiation of adult bone marrow progenitors into antigen-specific CD4 helper T cells using engineered stromal cells expressing a notch ligand and a major histocompatibility complex class II protein. Stem Cells Dev (2009) 0.80
Probing protease activity by single-fluorescent-protein nanocapsules. Chem Commun (Camb) (2010) 0.80
LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses. Lipids Health Dis (2014) 0.79
Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. Eur Neurol (2014) 0.79
Construction of stable producer cells to make high-titer lentiviral vectors for dendritic cell-based vaccination. Biotechnol Bioeng (2012) 0.79
A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. Vaccine (2012) 0.79
A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cells. J Vis Exp (2013) 0.79
[Protective effect of electroacupuncture intervention on neurovascular unit in rats with focal cerebral ischemia-reperfusion injury]. Zhen Ci Yan Jiu (2013) 0.78
Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells. J Biol Eng (2011) 0.78
Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule. Pharm Res (2009) 0.78
Xylose-fermenting Pichia stipitis by genome shuffling for improved ethanol production. Microb Biotechnol (2014) 0.78
Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag. Small (2012) 0.78
In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice. Biomacromolecules (2014) 0.77
Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virus. PLoS One (2011) 0.77
Tumor-specific, hypoxia-regulated, WW domain-containing oxidoreductase-expressing adenovirus inhibits human non-small cell lung cancer growth in vivo. Hum Gene Ther (2010) 0.77
[Clinical analysis of 47 patients with psoriasis arthropathy treated by traditional Chinese medicine syndrome differentiation and integrative medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2008) 0.77
Advanced glycation end product-induced astrocytic differentiation of cultured neurospheres through inhibition of Notch-Hes1 pathway-mediated neurogenesis. Int J Mol Sci (2013) 0.76
Serum insulin degrading enzyme level and other factors in type 2 diabetic patients with mild cognitive impairment. Curr Alzheimer Res (2016) 0.76
Antibody-mimetic ligand selected by mRNA display targets DC-SIGN for dendritic cell-directed antigen delivery. ACS Chem Biol (2013) 0.76
Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells. Hum Gene Ther (2011) 0.76
Dynamic variability of the heading-flowering stages of single rice in China based on field observations and NDVI estimations. Int J Biometeorol (2014) 0.75
Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization. Hum Gene Ther Methods (2014) 0.75
Controlling of explicit internal signal stochastic resonance by external signal. J Chem Phys (2004) 0.75
SATB1 binds an intronic MAR sequence in human PI3kgamma in vitro. Mol Biol Rep (2009) 0.75
[N-ras and fms gene mutation in idiopathic thrombocytopenic purpura and myelodysplasia]. Zhonghua Xue Ye Xue Za Zhi (2008) 0.75
[Impacts of moxibustion on vascular dementia and neuropeptide substance content in cerebral spinal fluid]. Zhongguo Zhen Jiu (2011) 0.75
Estimating the brain pathological age of Alzheimer's disease patients from MR image data based on the separability distance criterion. Phys Med Biol (2016) 0.75
[Development of Terahertz Imaging Technology in the Assessment of Burn Injuries]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2016) 0.75
[Clinical analysis for thrombocytopenia in 17 workers exposed to high concentration benzene]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2006) 0.75